The Hemostasis and Thrombosis Research Society (HTRS) has announced the availability of two new clinical fellowship awards (CFAs) in 2016. The CFAs, which will run for one academic year (July 1, 2016 - June 30, 2017), should focus on hemophilia and/or other rare bleeding disorders. The program is supported by an educational grant from Novo Nordisk, Inc.
During the fellowship year, awardees are mentored by MDs or DOs experienced in hemophilia or rare bleeding disorders at established US-based hemostasis treatment centers. Eligible applicants need to be adult or pediatric hematology/oncology MDs or DOs working in the US who will have completed a fellowship from an accredited US hematology, hematology/oncology or pediatric hematology/oncology training program by July 1, 2016. CFA applications are due by 6pm ET on Friday, January 15, 2016.
Access the complete request for proposals (RFPs) and learn more about the 2016 HTRS/Novo Nordisk Clinical Fellowship Awards in Hemophilia and Rare Bleeding Disorders by going to the HTRS web site. For questions about the CFAs, contact Laura or Lori in the HTRS office: [email protected] or 414.937.6569.
